| 1 |
33596797 | The Therapeutic Effects of Dihydroartemisinin on Cisplatin-Resistant Gastric Cancer Cells. | 2022 |
2 |
| 2 |
33777199 | Erratum: Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells. | 2021 May |
1 |
| 3 |
34884979 | Correction: Shao et al. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. Int. J. Mol. Sci. 2017, 18, 350. | 2021 Nov 24 |
1 |
| 4 |
32027258 | [Dihydroartemisinin Induces AML cell Apoptosis by Inhibition of PTEN/AKT pathway]. | 2020 Feb |
3 |
| 5 |
32072334 | Semi-synthetic product dihydroartemisinin inhibited fibronectin-1 and integrin-β1 and interfered with the migration of HCCLM6 cells via PI3K-AKT pathway. | 2020 Jun |
3 |
| 6 |
32237529 | [Preliminary study of dihydroartemisin in inhibiting invasion and metastasis of hepatoma cells]. | 2020 Feb |
1 |
| 7 |
32648887 | MOF nanoparticles with encapsulated dihydroartemisinin as a controlled drug delivery system for enhanced cancer therapy and mechanism analysis. | 2020 Aug 26 |
1 |
| 8 |
32831913 | Dihydroartemisinin inhibits the migration of esophageal cancer cells by inducing autophagy. | 2020 Oct |
3 |
| 9 |
33194761 | Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by Dihydroartemisinin Through Abrogating Immunity Escaping and Promoting Radiation Sensitivity by Inhibiting PD-L1 Expression. | 2020 |
1 |
| 10 |
33658929 | Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K. | 2020 |
3 |
| 11 |
30862567 | Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation. | 2019 Apr 15 |
2 |
| 12 |
31187708 | The Effect of Dihydroartemisinin on the Malignancy and Epithelial-Mesenchymal Transition of Gastric Cancer Cells. | 2019 |
1 |
| 13 |
31383247 | Dihydroartemisinin inhibits HepG2.2.15 proliferation by inducing cellular senescence and autophagy. | 2019 Aug |
1 |
| 14 |
31390552 | Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K/AKT pathway and downregulating HIF-1α expression. | 2019 Sep 15 |
2 |
| 15 |
31762815 | Dihydroartemisinin Induces Endothelial Cell Autophagy through Suppression of the Akt/mTOR Pathway. | 2019 |
3 |
| 16 |
29435054 | Dihydroartemisinin-induced apoptosis in human acute monocytic leukemia cells. | 2018 Mar |
3 |
| 17 |
30405828 | Dihydroartemisinin triggers c-Myc proteolysis and inhibits protein kinase B/glycogen synthase kinase 3β pathway in T-cell lymphoma cells. | 2018 Nov |
2 |
| 18 |
28208619 | AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. | 2017 Feb 10 |
4 |
| 19 |
28713965 | Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway. | 2017 Sep |
2 |
| 20 |
29262602 | Dihydroartemisinin inhibits EMT induced by platinum-based drugs via Akt-Snail pathway. | 2017 Nov 28 |
3 |
| 21 |
29926580 | [Effects of dihydroartemisinin on radiosensitivity of Raji cells]. | 2017 May 8 |
1 |
| 22 |
26743690 | Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts. | 2016 Jan 8 |
3 |
| 23 |
25301262 | Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway. | 2015 Mar |
1 |
| 24 |
26722323 | Dihydroartemisinin inhibits the Raf/ERK/MEK and PI3K/AKT pathways in glioma cells. | 2015 Nov |
2 |
| 25 |
23929438 | Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells. | 2014 Jan |
1 |
| 26 |
25674233 | Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells. | 2014 |
2 |
| 27 |
23201011 | Dihydroartemisinin inhibits the Bcr/Abl oncogene at the mRNA level in chronic myeloid leukemia sensitive or resistant to imatinib. | 2013 Mar |
1 |
| 28 |
22833150 | Growth inhibitory effect of dihydroartemisinin on Bcr/Abl+ chronic myeloid leukemia K562 cells involve AKT, ERK and NF-κB modulation. | 2012 Dec |
1 |
| 29 |
22993204 | Dihydroartemisinin ameliorates inflammatory disease by its reciprocal effects on Th and regulatory T cell function via modulating the mammalian target of rapamycin pathway. | 2012 Nov 1 |
1 |
| 30 |
20224297 | Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells. | 2010 May 15 |
1 |